How an East Bay cancer fighter — once kicked to the curb by Big Pharma — picked up its 4th drug approval By: San Francisco Business Times via Business Journals January 15, 2019 at 09:32 AM EST The Alameda company now has won FDA approval of the drug in thyroid, kidney and liver cancer. Read More >>
